TECX Tectonic Therapeutic, Inc.

Overview and Growth

Fiscal 2025 results for Tectonic Therapeutic, Inc. included net loss of $74.15M. Diluted earnings per share were -$4.05, translating the period’s attributable earnings into the amount reported for each diluted share. The diluted weighted-average share count was 18.32M, linking total earnings with the per-share result received by shareholders. Compared with 8.49M diluted shares in fiscal 2024, the current 18.32M base was 115.8% higher. The company employed $261.04M of total assets, the balance-sheet base supporting its current operating and cash-flow results.

Profitability

The reported operating result was an operating loss of $84.04M, reflecting costs that exceeded gross profit. After all below-operating-line items, the company recorded a net loss of $74.15M for the fiscal year. The company reported negative EBITDA of $82.66M, adding a pre-interest, tax, depreciation, and amortization view of the operating shortfall. The pretax result was a loss of $72.92M, establishing the deficit before tax effects. The reported income-tax provision was $1.23M, the amount recognized between pretax income and the final net-income result. Relative to period-end equity, the net loss represented 29.5%. The net loss equaled 28.4% of period-end assets, showing the deficit relative to the asset base. The net loss widened to $74.15M from $57.98M in fiscal 2024.

Liquidity and Capital Structure

The company held $261.04M of assets against $9.71M of liabilities and $251.33M of equity, revealing how the asset base was financed. The near-term balance sheet paired $257.36M of current assets with $9.67M of current liabilities at the reporting date. At 26.63x, the current ratio shows that short-term assets were greater than short-term liabilities at period end. The company held $253.80M in cash and equivalents, a narrower liquidity measure than total current assets. Book equity represented 96.3% of total assets, quantifying the balance-sheet share supported by shareholder capital. The liabilities-to-assets relationship was 3.7%, placing reported obligations against the full positive asset balance. Measured against total assets, cash and equivalents represented 97.2%, a balance-sheet composition measure rather than a liquidity forecast. Total assets were 70.7% higher than fiscal 2024 assets of $152.91M, measuring the company’s own balance-sheet change. Book equity was 78.5% higher than fiscal 2024 equity of $140.78M, showing how shareholder capital changed year over year. Compared with $141.24M in fiscal 2024, the current cash balance moved 79.7% and finished higher.

Cash Flow and Earnings Quality

Operating activities used $60.08M of cash, resulting in an operating cash outflow for the year. Capital expenditures used $208.00K in addition to the operating cash outflow, increasing the total cash consumed by operations and investment during the period. The company recorded a $60.29M cash deficit after capital spending for the period. The free-cash-flow deficit equaled 23.1% of total assets, placing the cash shortfall against the company’s resource base. The operating cash outflow widened to $60.08M from $59.08M in fiscal 2024.

Based on the annual report for the fiscal year ending Dec 31, 2025. Analysis generated Oct 21, 2026.